Sensitivity of Daudi cells to tumor necrosis factor alpha: early changes in polyphosphoinositide metabolism

E Santavenere1, R Di Pietro, L Di Domenicantonio

  • 1Istituto di Morfologia Umana Normale, Chieti, Italy.

Cell Biology International
|September 1, 1996
PubMed

Insights

Recombinant Tumor Necrosis Factor alpha (r-TNF alpha) alters polyphosphoinositide metabolism in Daudi cells, reducing key lipid incorporation. This study reveals early metabolic changes during the cytokine

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Immunology

Background:

  • Tumor Necrosis Factor alpha (TNF alpha) is a key cytokine involved in inflammation and immune responses.
  • Polyphosphoinositides are crucial signaling lipids involved in various cellular processes.
  • Previous studies indicated TNF alpha can induce polyphosphoinositide breakdown in certain cell types.

Purpose of the Study:

  • To investigate the effects of recombinant TNF alpha (r-TNF alpha) on polyphosphoinositide metabolism in Daudi cells.
  • To identify early changes in lipid metabolism associated with the antiproliferative response to r-TNF alpha.

Main Methods:

  • Daudi cells were treated in vitro with r-TNF alpha.
  • The incorporation of 32Pi into phosphatidylinositol (PtdIns), phosphatidylinositol 4-phosphate (PtdInsP), and phosphatidylinositol 4,5-phosphate (PtdInsP2) was measured.

Main Results:

  • r-TNF alpha treatment led to a significant reduction in the incorporation of 32Pi into PtdIns, PtdInsP, and PtdInsP2.
  • These changes were observed after 1 hour of in vitro treatment.
  • The findings confirm previous observations of PtdIns breakdown induced by r-TNF alpha.

Conclusions:

  • This study demonstrates early alterations in polyphosphoinositide metabolism in Daudi cells following r-TNF alpha treatment.
  • These metabolic changes are linked to the antiproliferative effects of TNF alpha in Burkitt Lymphoma cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...